GlaxoSmithkline Consumer Healthcare jumps on reporting 14% rise in Q3 net profit

06 Nov 2013 Evaluate

GlaxoSmithkline Consumer Healthcare is currently trading at Rs. 4754.00, up by 114.75 points or 2.47% from its previous closing of Rs. 4639.25 on the BSE.

The scrip opened at Rs. 4670.80 and has touched a high and low of Rs. 4814.30 and Rs. 4641.60 respectively. So far 4650 shares were traded on the counter.

The BSE group 'A' stock of face value Rs. 10 has touched a 52 week high of Rs. 6020.00 on 31-May-2013 and a 52 week low of Rs. 2980.00 on 12-Nov-2012.

Last one week high and low of the scrip stood at Rs. 4747.00 and Rs. 4550.00 respectively. The current market cap of the company is Rs. 19,949 crore.

The promoters holding in the company stood at 72.46% while Institutions and Non-Institutions held 12.22% and 15.33% respectively.

The company has reported 14.30% rise in its net profit at Rs 146.93 crore for the quarter as compared to Rs 128.55 crore for the same quarter in the previous year. Total income of the company has increased by 19.45% at Rs 1057.47 crore for quarter under review as compared to Rs 885.31 crore for the quarter ended September 30, 2012.

GlaxoSmithKline Pharmaceuticals is one oldest pharmaceutical company in India. Internationally it has created many brands such as Ribena, Horlicks, Lucozade, Aquafresh, Sensodyne, Panadol, Tums and Zovirax, among others. It employs 5,000 people and has turnover of more than $1 billion in India.

Glaxo.Cons. Health Share Price

9696.40 0.00 (0.00%)
15-Apr-2020 18:01 View Price Chart
Peers
Company Name CMP
Nestle 1246.65
Varun Beverages 479.95
Britannia Inds 5961.10
LT Foods 397.00
Hatsun Agro Product 1034.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×